Skip to main content
Top
Published in: Breast Cancer Research and Treatment 2/2017

01-04-2017 | Erratum

Erratum to: Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis

Authors: Simona F. Shaitelman, Yi-Ju Chiang, Kate D. Griffin, Sarah M. De Snyder, Benjamin D. Smith, Mark V. Schaverien, Wendy A. Woodward, Janice N. Cormier

Published in: Breast Cancer Research and Treatment | Issue 2/2017

Login to get access

Excerpt

In the original publication of the article, the co-author names were missed out inadvertently. The corrected author group is given in this erratum. The original article was corrected. …
Metadata
Title
Erratum to: Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis
Authors
Simona F. Shaitelman
Yi-Ju Chiang
Kate D. Griffin
Sarah M. De Snyder
Benjamin D. Smith
Mark V. Schaverien
Wendy A. Woodward
Janice N. Cormier
Publication date
01-04-2017
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2017
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-017-4116-9

Other articles of this Issue 2/2017

Breast Cancer Research and Treatment 2/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine